ProQR Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $2,915 | $3,817 | $4,519 | $4,307 |
Gross Profit | 2,915 | 3,817 | 4,519 | 4,307 |
EBITDA | -10,335 | -11,574 | -10,138 | -5,821 |
EBIT | -11,006 | -12,249 | -10,816 | -6,492 |
Net Income | -11,006 | -12,179 | -10,079 | -9,305 |
Net Change In Cash | 2,915 | 3,817 | 4,519 | 4,307 |
Free Cash Flow | -12,404 | -11,502 | -16,022 | -9,481 |
Cash | 106,883 | 119,765 | 143,033 | 149,408 |
Basic Shares | 110,060 | 105,343 | 105,296 | 81,665 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $18,905 | $6,514 | $3,594 | $1,335 |
Gross Profit | 18,905 | 6,514 | 3,594 | 1,335 |
EBITDA | -24,122 | -24,097 | -56,460 | -54,948 |
EBIT | -26,883 | -26,610 | -58,981 | -57,277 |
Net Income | -27,763 | -28,119 | -64,424 | -60,740 |
Net Change In Cash | 18,905 | 6,514 | 3,594 | 1,335 |
Free Cash Flow | -37,811 | 20,177 | -69,216 | -26,496 |
Cash | 149,408 | 131,370 | 94,775 | 187,524 |
Basic Shares | 81,665 | 81,011 | 71,641 | 64,182 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.10 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.11 |
